Literature DB >> 32193211

Preventing Asthma Emergencies in Schools.

Amy O'Rourke1,2, Amy Zimmerman3, Hayley Platt3, Andrea A Pappalardo4,5.   

Abstract

Asthma is a significant public health issue, impacting quality of life, morbidity, and health care costs nationally. Stock asthma rescue medication policies authorize school districts to maintain unassigned albuterol and enable trained staff members to administer the medication in response to asthma symptoms, exercise premedication, and asthma emergencies. Stock asthma rescue (or reliever) medication laws serve as an important fail-safe measure. Such laws provide districts with the ability to respond if a student has an asthma emergency at school but either lacks a diagnosis or does not have access to their own medication. As of September 2019, 13 states have enacted either a law or regulation authorizing the stocking of asthma rescue medication in schools: Arizona, Colorado, Georgia, Illinois, Missouri, New Hampshire, New Jersey, New Mexico, Oklahoma, Ohio, Texas, Utah, and West Virginia. Three additional states provide stock albuterol asthma guidelines but do not have legislation: Indiana, New York, and Nebraska. Some states have found that these policies reduce the need for 911 calls and emergency medical services transports as a result of asthma exacerbations. Initial data also demonstrate that these policies reach populations in need and improve health outcomes. This case study will describe the current state of asthma in Illinois, an innovative policy solution to address asthma emergencies in schools, and the steps taken to advocate for stock asthma rescue medication in Illinois. Legislation for stock albuterol in Illinois was signed into law in August 2018.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Year:  2020        PMID: 32193211     DOI: 10.1542/peds.2019-1995

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  1 in total

1.  Ensuring Access to Albuterol in Schools: From Policy to Implementation. An Official ATS/AANMA/ALA/NASN Policy Statement.

Authors:  Anna Volerman; Ashley A Lowe; Andrea A Pappalardo; Charmayne M C Anderson; Kathryn V Blake; Tyra Bryant-Stephens; Thomas Carr; Heather Carter; Lisa Cicutto; Joe K Gerald; Tina Miller; Nuala S Moore; Hanna Phan; S Christy Sadreameli; Andrea Tanner; Tonya A Winders; Lynn B Gerald
Journal:  Am J Respir Crit Care Med       Date:  2021-09-01       Impact factor: 21.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.